D.A. Davidson & CO. increased its holdings in shares of Healthcare Trust of America, Inc. (NYSE:HTA) by 5.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,241 shares of the real estate investment trust’s stock after acquiring an additional 1,685 shares during the quarter. D.A. Davidson & CO.’s holdings in Healthcare Trust of America were worth $901,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in Healthcare Trust of America by 34.1% during the second quarter. Vanguard Group Inc. now owns 29,518,137 shares of the real estate investment trust’s stock worth $918,310,000 after acquiring an additional 7,510,727 shares during the period. BlackRock Inc. raised its stake in Healthcare Trust of America by 44.3% during the second quarter. BlackRock Inc. now owns 13,050,386 shares of the real estate investment trust’s stock worth $405,999,000 after acquiring an additional 4,003,376 shares during the period. Daiwa Securities Group Inc. raised its stake in Healthcare Trust of America by 14.2% during the third quarter. Daiwa Securities Group Inc. now owns 11,858,804 shares of the real estate investment trust’s stock worth $353,393,000 after acquiring an additional 1,476,407 shares during the period. Cbre Clarion Securities LLC raised its stake in Healthcare Trust of America by 56.9% during the second quarter. Cbre Clarion Securities LLC now owns 8,181,898 shares of the real estate investment trust’s stock worth $254,539,000 after acquiring an additional 2,965,936 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in Healthcare Trust of America by 39.1% during the third quarter. Bank of New York Mellon Corp now owns 7,715,128 shares of the real estate investment trust’s stock worth $229,911,000 after acquiring an additional 2,166,703 shares during the period. Hedge funds and other institutional investors own 98.09% of the company’s stock.

Healthcare Trust of America, Inc. (NYSE:HTA) opened at $30.89 on Monday. Healthcare Trust of America, Inc. has a 12 month low of $27.47 and a 12 month high of $33.00. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 0.88. The company has a market cap of $6,328.93, a P/E ratio of 18.84, a P/E/G ratio of 4.69 and a beta of 0.31.

Healthcare Trust of America (NYSE:HTA) last posted its quarterly earnings data on Tuesday, October 24th. The real estate investment trust reported $0.07 EPS for the quarter, missing the Zacks’ consensus estimate of $0.41 by ($0.34). Healthcare Trust of America had a net margin of 6.75% and a return on equity of 1.50%. The company had revenue of $176.00 million for the quarter, compared to analyst estimates of $163.62 million. During the same quarter in the prior year, the business earned $0.40 EPS. Healthcare Trust of America’s revenue was up 48.8% compared to the same quarter last year. research analysts expect that Healthcare Trust of America, Inc. will post 1.65 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 9th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.305 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 3.95%. Healthcare Trust of America’s dividend payout ratio is presently 508.35%.

Several research firms recently weighed in on HTA. SunTrust Banks, Inc. set a $36.00 price objective on shares of Healthcare Trust of America and gave the stock a “buy” rating in a research note on Tuesday, October 24th. Stifel Nicolaus raised their price target on shares of Healthcare Trust of America from $34.00 to $35.00 and gave the company a “hold” rating in a research note on Wednesday, October 25th. Zacks Investment Research lowered shares of Healthcare Trust of America from a “hold” rating to a “sell” rating in a research note on Wednesday, September 6th. BidaskClub lowered shares of Healthcare Trust of America from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Finally, BMO Capital Markets restated a “buy” rating and issued a $35.00 price target on shares of Healthcare Trust of America in a research note on Monday, October 2nd. Five investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $34.20.

TRADEMARK VIOLATION WARNING: “D.A. Davidson & CO. Grows Position in Healthcare Trust of America, Inc. (HTA)” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/d-a-davidson-co-grows-position-in-healthcare-trust-of-america-inc-hta/1729080.html.

About Healthcare Trust of America

Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Want to see what other hedge funds are holding HTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Trust of America, Inc. (NYSE:HTA).

Institutional Ownership by Quarter for Healthcare Trust of America (NYSE:HTA)

Receive News & Ratings for Healthcare Trust of America Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust of America Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.